Medical Device News Magazine

Babson Diagnostics Welcomes New Clinical Advisor, Dr Andrew Carroll

Healthtech company adds key clinical expertise as it moves closer to commercialization of its next-generation blood testing ecosystem

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Babson Diagnostics, a science-first health care technology company, today announced the addition of a clinical advisor who will bring valuable insights of the medical community in the ongoing development and introduction of the company’s new diagnostic blood testing service, BetterWay™. Andrew Carroll, M.D., a family physician and clinical assistant professor at the University of Arizona College of Medicine, will provide advice and counsel about clinical best practices and review validation data and reports.

Dr Andrew Carroll is a leading voice in family medicine, having served on the board of directors of the American Academy of Family Physicians, a professional organization representing more than 130,000 doctors. He also has extensive experience in the areas of new healthcare delivery models, healthcare information technology, and medical informatics.

“Dr. Carroll joins the Babson team as a highly recognized leader in the industry and brings first-hand clinical experience as we move closer to launch,” said David Stein, Babson’s chief executive officer. “His deep understanding of what is critical to physicians and their patients will bring value and clinical guidance to fulfilling Babson’s mission of making blood testing easier and patient-centered.”

Babson’s BetterWay blood testing reimagines diagnostic testing – from collection to sample preparation to analysis. Requiring only a pea-sized capillary sample from a finger, BetterWay is designed to eliminate the need for collection of large tubes of blood for analysis while maintaining medically accurate results clinicians and their patients can trust.

Dr. Carroll will join Babson at industry events, trade shows, and clinical meetings. He will also assist in assembling a clinical advisory board to support the company in embedding clinical best practices.

Dr. Carroll is the founder, owner and medical director at Atembis LLC in Chandler, Arizona, where he is focused on providing cost-conscientious care for patients who are not eligible for federal or state insurance benefits.

“Effective care starts with having the best health information about your patients and much of that critical data comes from blood testing,” Dr. Carroll said. “I love collaborating with innovative companies like Babson who are focused on making health easier for all.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”